Letter from Representative Waxman to Dr. Varmus regarding deaths in protocols overseen by RAC and FDA
Nov 23, 1999 Issues: Health
In a letter to Dr. Varmus, Director of the National Institutes of Health, Rep. Waxman writes concerning the recent deaths in a number of human gene therapy protocols overseen by both the NIH’s Recombinant DNA Advisory Committee and the Food and Drug Administration.
